相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ozoralizumab, a Humanized Anti-TNFα NANOBODY(R) Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG
Chihiro Ishiwatari-Ogata et al.
FRONTIERS IN IMMUNOLOGY (2022)
Ozoralizumab for rheumatoid arthritis
Jennifer Thorley
LANCET RHEUMATOLOGY (2022)
Phase II/III Results of a Trial of Anti-Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis
Tsutomu Takeuchi et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Nanobody: a promising toolkit for molecular imaging and disease therapy
Guangfa Bao et al.
EJNMMI RESEARCH (2021)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Serum albumin-binding VHHs with variable pH sensitivities enable tailored half-life extension of biologics
Henk van Faassen et al.
FASEB JOURNAL (2020)
Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120
Tsutomu Takeuchi et al.
MODERN RHEUMATOLOGY (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies
Farnaz Khodabakhsh et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)
Bivalent llama single-Domain antibody Fragments against Tumor necrosis Factor have Picomolar Potencies due to intramolecular interactions
Els Beirnaert et al.
FRONTIERS IN IMMUNOLOGY (2017)
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
Jay Tibbitts et al.
MABS (2016)
Cytokines in rheumatoid arthritis - shaping the immunological landscape
Iain B. McInnes et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Treatment of rheumatoid arthritis: Unraveling the conundrum
Evangelia Zampeli et al.
JOURNAL OF AUTOIMMUNITY (2015)
Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study
Nobuyuki Miyasaka et al.
Modern Rheumatology (2014)
Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial
Kazuhiko Yamamoto et al.
MODERN RHEUMATOLOGY (2014)
Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2014)
Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial
Kazuhiko Yamamoto et al.
MODERN RHEUMATOLOGY (2014)
Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24weeks
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study
Yoshiya Tanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The Japanese experience with biologic therapies for rheumatoid arthritis
Tsutomu Takeuchi et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Janusz Wesolowski et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Properties, production, and applications of camelid single-domain antibody fragments
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Formatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
Ken Coppieters et al.
ARTHRITIS AND RHEUMATISM (2006)
Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
A Wunder et al.
JOURNAL OF IMMUNOLOGY (2003)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
